In this review, we summarize the advantages/disadvantages of these therapeutic agents, providing a critical view of whether they could be effective in the human clinic
Tesamorelin is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) that stimulates the pituitary gland to secrete growth hormone
Kaku K, Yamada Y, Watada H, Abido A, Nishida T, Zacho J, Kiyosue A
10.1155/2013/653789 Summary Keywords GLP-1, liraglutide, semaglutide, type 2 diabetes, obesity, albumin, once-weekly Citation Knudsen LB and Lau J (2019) The Discovery and Development of Liraglutide and Semaglutide
The data on these drugs is already stark: Between 810% of Americans are currently using GLP-1 drugs (roughly the population of Texas) Projections suggest that by 2030 this will rise to 1415% Americans - with global demand also expected to surge Users of these GLP-1 drugs are cutting their grocery spending by up to 9%, with consumption of snacks, sweets, and sugary drinks plummeting Morgan Stanley predicts a 3-4% drop in these categories by 2035, with some estimates much higher This isn't a fad, it's a growing threat to brands built on indulgence and an enormous opportunity for those ready to adapt
Wegovy Pill: What It Is, How It Works and When You Can Get It Wegovy Pill is the first GLP-1 oral pill approved for weight loss in the UK